Cytomegalovirus in Solid Organ Transplantation

This publication has 90 references indexed in Scilit:

• In Vitro Evaluation of the Activities of the Novel Anticytomegalovirus Compound AIC246 (Letermovir) against Herpesviruses and Other Human Pathogenic Viruses
  Antimicrobial Agents and Chemotherapy, 2012
• Factors Contributing to Variability of Quantitative Viral PCR Results in Proficiency Testing Samples: a Multivariate Analysis
  Journal of Clinical Microbiology, 2012
• Cyclopropavir Susceptibility of Cytomegalovirus DNA Polymerase Mutants Selected after Antiviral Drug Exposure
  Antimicrobial Agents and Chemotherapy, 2012
• Progress in the development of new therapies for herpesvirus infections
  Current Opinion in Virology, 2011
• The Novel Anticytomegalovirus Compound AIC246 (Letermovir) Inhibits Human Cytomegalovirus Replication through a Specific Antiviral Mechanism That Involves the Viral Terminase
  Journal of Virology, 2011
• Human cytomegalovirus kinetics following institution of artesunate after hematopoietic stem cell transplantation
  Antiviral Research, 2011
• Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
  The Lancet, 2011
• Antiviral Drug Resistance of Human Cytomegalovirus
  Clinical Microbiology Reviews, 2010
• Valacyclovir for the Prevention of Cytomegalovirus Disease after Renal Transplantation
  New England Journal of Medicine, 1999
• OKT3 Treatment for Allograft Rejection Is a Risk Factor for Cytomegalovirus Disease in Liver Transplantation
  The Journal of Infectious Diseases, 1995